Click: 0

Search: 0

This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Pharmacy
Medicine
Nurses
Marketing
Research
Behavioural Health
Clinical Research
Clinical Supply
Vaccination

Clinical Research Informer

Expert insights. Personalized for you.

brought to you by

Evolution Summit

brought to you by Evolution Summit

Search:

See the top articles from:

DAY

WEEK

MONTH

YEAR

MORE monthly editions

MORE yearly editions

Select your country:
Sign up | Log in

Search:

Select your country:

Topics
Resources
Learn More
What's This?

Sign up | Log in
Topics
Resources
Learn More
What's This?
See all the top articles from
- DAY
- WEEK
- MONTH
- YEAR
  - This Year
  - Last Year
  - 2022
  - 2021
  - 2020
  - 2019

Sat.Aug 03, 2024

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

AUGUST 3, 2024

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim a

Drugs

Drugs Branding Marketing

Which pharmaceutical companies have the most drug patents in Eurasian Patent Organization?

Drug Patent Watch

AUGUST 3, 2024

This chart shows the pharmaceutical companies with the most patents in Eurasian Patent Organization.

Drugs

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stay Connected

Join 21,000+ Insiders by signing up for our newsletter

About

Learn More
Participate in Clinical Research Informer
Support
Add a Source
Add a Resource
Advertise

About

Learn More
Participate in Clinical Research Informer
Support
Add a Source
Add a Resource
Advertise

Editions

Sun. Oct 06
Sat. Oct 05
Fri. Oct 04
Thu. Oct 03
Sep 28 - Oct 04

Editions

Sun. Oct 06
Sat. Oct 05
Fri. Oct 04
Thu. Oct 03
Sep 28 - Oct 04

Topics

Sales
Antibody
FDA Compliance
Immune Response
Laboratory Information Management System
Clinical Trials
More Topics

Input your email to sign up, or if you already have an account, log in here!

Remember me I forgot my password

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Enter your email address to reset your password.
A temporary password will be e‑mailed to you.

Nevermind, I remember my password

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BE IN THE KNOW ON

Clinical Research Informer

Expert insights. Personalized for you.

We organize all of the trending information in your field so you don't have to.
Join 21,000+ users and stay up to date on the latest articles your peers are reading.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Newsletter
About You
Verify
Interests
Company

Get the good stuff

Subscribe to the following Clinical Research Informer newsletters:

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

You must accept the Privacy Policy and Terms & Conditions to proceed.

Agree to Terms and Conditions and Privacy Policy

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

If you do provide consent, you may change your mind and unsubscribe at any time. If you would like to unsubscribe or have any questions, you can click on the unsubscribe links in our messages or contact us using the information below. For information about how we use information you provide to us, please read our Privacy Policy.

For Canadian Residents: By providing your consent below, you are expressly agreeing that we may email you under Canada's Anti-Spam Law. For more information on this law, you may visit the Government of Canada's site.

For European Union Residents: By providing your consent below, you are expressly agreeing that we may email you under European Union General Data Protection Regulation (Regulation (EU) 2016/679). For more information on this regulation, you may visit the European Union's site. Additional details.

Contact Information:
Aggregage
info@aggregage.com
525 South Douglas St., Suite 260, El Segundo, CA 90245

You know about us, now we want to get to know you!

Check your mail

We've sent an email to . Please verify that you have received the email.

We have resent the email to

Let's personalize your content

Use social media to find articles

We can use your profile and the content you share to understand your interests and provide content that is just for you.

Turn this off at any time. Your social media activity always remains private.

Let's get even more personalized

Choose topics that interest you.

So, what do you do?

Are you sure you want to cancel your subscriptions?

Changing Country?

Accept Terms & Conditions

It looks like you are changing your country/region of residence. In order to receive our emails, you must expressly agree. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of our emails.

You appear to have previously removed your acceptance of the Terms & Conditions.

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

Agree to Terms and Conditions and Privacy Policy

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

We noticed that you changed your country/region of residence; congratulations! In order to make this change, you must accept the Aggregage Terms and Conditions and Privacy Policy. Once you've accepted, then you will be able to choose which emails to receive from each site.

You appear to have previously removed your acceptance of the Terms & Conditions.

You must choose one option

Agree to Terms and Conditions and Privacy Policy

Cancel country change

Cancel all of my subscriptions

Please choose which emails to receive from each site.

Update All Sites
Update Each Site

Please verify your previous choices for all sites

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

Sites have been updated - click Submit All Changes below to save your changes.

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

Newsletter
About You
Interests

Get the good stuff

Subscribe to the following Clinical Research Informer newsletters:

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

You must accept the Privacy Policy and Terms & Conditions to proceed.

Agree to Terms and Conditions and Privacy Policy

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

You know about us, now we want to get to know you!

We've sent an email to . Please verify that you have received the email.

We have resent the email to

Let's personalize your content

Use social media to find articles

We can use your profile and the content you share to understand your interests and provide content that is just for you.

Turn this off at any time. Your social media activity always remains private.

Let's get even more personalized

Choose topics that interest you.

We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.

Subscribe to the following Clinical Research Informer newsletters:

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

You must accept the Privacy Policy and Terms & Conditions to proceed.

Agree to Terms and Conditions and Privacy Policy

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

This is not me

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.